Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding
Safety: Gradual increases allow better monitoring for side effects
Yes, your first consultation is completely free with no commitment
Supplies Needed Quantities below assume a research cycle of about 46 weeks
Contact your healthcare provider if you experience: Absent periods (amenorrhea): Missing three or more consecutive menstrual cycles if previously regular, or six or more months if previously irregular Heavy bleeding (menorrhagia): Soaking through a pad or tampon every hour for several consecutive hours, or periods lasting longer than seven days Severe pain: New or worsening menstrual cramping not relieved by over-the-counter medications Intermenstrual bleeding: Bleeding or spotting between periods that persists beyond initial treatment months Pregnancy possibility: Any missed period when pregnancy is possible, as tirzepatide is not recommended during pregnancy Urgent warning signs: Heavy bleeding with dizziness, fainting, rapid heartbeat, or severe weakness requires emergency evaluation Your healthcare provider may recommend specific investigations to evaluate persistent menstrual irregularities
US$ 27.45
US$ 28.19
US$ 21.37
US$ 21.76
US$ 26.22
US$ 23.67
US$ 22.74
US$ 20.36
US$ 21.68
US$ 28.53
US$ 27.68
US$ 27.14